Richard Francis
Vorstandsvorsitzender bei
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Vermögen: 41 Mio $ am 31.05.2026
Profil
Richard Francis is President, Chief Executive Officer & Director at Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. since 2023.
Mr. Francis is Director at Mettler-Toledo (Schweiz) GmbH since 2016 and Director at Purespring Therapeutics Ltd. since 2021.
Former roles include Chief Executive Officer & Division Head at Sandoz International GmbH from 2014 to 2019, Chief Executive Officer at Forcefield Therapeutics Ltd., Independent Director at Mettler-Toledo International, Inc. from 2016 to 2025, and Senior Vice President at Biogen, Inc. from 2006 to 2014.
Education includes an undergraduate degree from Manchester Metropolitan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 1.177.529 ( 0,1 % ) | 41 Mio $ | 31.05.2026 |
Aktuelle Nachrichten zu Richard Francis
Aktive Positionen von Richard Francis
| Unternehmen | Position | Beginn |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Vorstandsvorsitzender | 01.01.2023 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Direktor/Vorstandsmitglied | 01.01.2023 |
Mettler-Toledo (Schweiz) GmbH
 Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Direktor/Vorstandsmitglied | 01.05.2016 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Vorstandsvorsitzender | 01.01.2023 |
Ehemalige bekannte Positionen von Richard Francis
| Unternehmen | Position | Ende |
|---|---|---|
| METTLER-TOLEDO INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 01.05.2025 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Vorstandsvorsitzender | 31.03.2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2014 |
Forcefield Therapeutics Ltd.
 Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Vorstandsvorsitzender | - |
Ausbildung von Richard Francis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mettler-Toledo International, Inc.
 Mettler-Toledo International, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies precision instruments | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Manchester Metropolitan University
 Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mettler-Toledo (Schweiz) GmbH
Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Producer Manufacturing |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Forcefield Therapeutics Ltd.
Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Health Technology |
